| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04375904 | 'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours… | NSCLC/Oligometastatic Cancer (Single Lung Lesion) | Recruiting |
| NCT07552168 | INSPIRE: INnovative SABR for Prostate Cancer All IREland | Prostate Adenocarcinoma | Recruiting |
| NCT05710666 | Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in… | HER2-positive Breast Cancer | Active, Not Recruiting |
| NCT05123131 | Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma | Multiple Myeloma | Active, Not Recruiting |
| NCT00951535 | A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate… | Prostate Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06078813 | Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid… | Solid Tumor Spine Metastases | Recruiting |
| NCT06024824 | Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) | Pancreatic Adenocarcinoma | Recruiting |
| Phase 1 | |||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | Multiple Myeloma | Active, Not Recruiting |
| Not specified | |||
| NCT06149546 | Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing… | Pancreatic Cancer | Recruiting |
| NCT01840293 | Breast Cancer Proteomics and Molecular Heterogeneity | Primary Breast Cancer | Recruiting |
| NCT07425002 | Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer… | Breast Cancer | Recruiting |
| NCT02050750 | TAILORx Tissue Bank | Breast Cancer | Active, Not Recruiting |